Personalis at Neoantigen Summit Europe:  APR 24-26, 2018


Sean Michael Boyle, PhD
Director, Bioinformatics Applications
Personalis, Inc.

From Sample to Neoantigens for Vaccines:
Key Challenges and Solutions

Points that will be covered in his presentation:

  • cfDNA neoantigens: dealing with tumor heterogeneity
  • Improving neoantigen identification
  • Elaborating TME, immuno-modulators and vaccine response biomarkers
  • Overcoming poor sample quality and quantity for NGS sequencing
  • Overcoming sequencing gaps that can harbor neoantigens
  • Validation and regulatory issues on the way to commercialization